Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raptiva in Adults With Plaque Psoriasis (ACD2391g)
NCT00109252Phase 3Completed
- Sponsor
- Genentech
- Start
- Jan 2002
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
01
Overview
A Phase 3 trial of efalizumab, sponsored by Genentech. Started Jan 2002; status: completed.
02
Drugs
efalizumab
Beyond the preview
Go deeper on NCT00109252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109252.